The New India Assurance Company Limited

NSEI:NIACL Stock Report

Market Cap: ₹281.1b

New India Assurance Valuation

Is NIACL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NIACL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NIACL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NIACL's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NIACL?

Key metric: As NIACL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NIACL. This is calculated by dividing NIACL's market cap by their current earnings.
What is NIACL's PE Ratio?
PE Ratio16.5x
Earnings₹17.01b
Market Cap₹281.08b

Price to Earnings Ratio vs Peers

How does NIACL's PE Ratio compare to its peers?

The above table shows the PE ratio for NIACL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average73.2x
GODIGIT Go Digit General Insurance
104.4x29.9%₹298.9b
ICICIGI ICICI Lombard General Insurance
40.1x15.3%₹893.4b
STARHEALTH Star Health and Allied Insurance
31.2x18.4%₹269.1b
MFSL Max Financial Services
117.1x22.9%₹403.2b
NIACL New India Assurance
16.5x-5.6%₹281.1b

Price-To-Earnings vs Peers: NIACL is good value based on its Price-To-Earnings Ratio (16.5x) compared to the peer average (73.2x).

Price to Earnings Ratio vs Industry

How does NIACL's PE Ratio compare vs other companies in the Asian Insurance Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
NIACL 16.5xIndustry Avg. 11.0xNo. of Companies46PE0816243240+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NIACL is expensive based on its Price-To-Earnings Ratio (16.5x) compared to the Asian Insurance industry average (11x).

Price to Earnings Ratio vs Fair Ratio

What is NIACL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NIACL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.5x
Fair PE Ratio14.8x

Price-To-Earnings vs Fair Ratio: NIACL is expensive based on its Price-To-Earnings Ratio (16.5x) compared to the estimated Fair Price-To-Earnings Ratio (14.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NIACL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹170.56
₹232.00
+36.0%
26.7%₹294.00₹170.00n/a2
Nov ’25₹199.56
₹237.00
+18.8%
24.1%₹294.00₹180.00n/a2
Oct ’25₹231.90
₹237.00
+2.2%
24.1%₹294.00₹180.00n/a2
Sep ’25₹264.85
₹237.00
-10.5%
24.1%₹294.00₹180.00n/a2
Aug ’25₹279.85
₹237.00
-15.3%
24.1%₹294.00₹180.00n/a2
Jul ’25₹245.49
₹237.00
-3.5%
24.1%₹294.00₹180.00n/a2
Jun ’25₹228.75
₹135.00
-41.0%
33.3%₹180.00₹90.00n/a2
May ’25₹247.15
₹130.00
-47.4%
30.8%₹170.00₹90.00n/a2
Apr ’25₹239.75
₹130.00
-45.8%
30.8%₹170.00₹90.00n/a2
Mar ’25₹268.80
₹130.00
-51.6%
30.8%₹170.00₹90.00n/a2
Feb ’25₹239.85
₹125.33
-47.7%
21.7%₹156.00₹90.00n/a3
Jan ’25₹216.60
₹125.33
-42.1%
21.7%₹156.00₹90.00n/a3
Dec ’24₹231.25
₹110.00
-52.4%
14.8%₹130.00₹90.00n/a3
Nov ’24₹137.05
₹110.00
-19.7%
14.8%₹130.00₹90.00₹199.563
Oct ’24₹140.50
₹110.00
-21.7%
14.8%₹130.00₹90.00₹231.903
Sep ’24₹129.95
₹110.00
-15.4%
14.8%₹130.00₹90.00₹264.853
Aug ’24₹126.20
₹105.00
-16.8%
11.7%₹120.00₹90.00₹279.853
Jul ’24₹116.95
₹105.00
-10.2%
11.7%₹120.00₹90.00₹245.493
Jun ’24₹119.50
₹108.33
-9.3%
7.8%₹120.00₹100.00₹228.753
May ’24₹105.80
₹105.00
-0.8%
10.3%₹120.00₹95.00₹247.153
Apr ’24₹97.30
₹105.00
+7.9%
10.3%₹120.00₹95.00₹239.753
Mar ’24₹102.95
₹105.00
+2.0%
10.3%₹120.00₹95.00₹268.803
Feb ’24₹109.60
₹97.67
-10.9%
7.3%₹105.00₹88.00₹239.853
Jan ’24₹125.75
₹92.33
-26.6%
9.9%₹105.00₹84.00₹216.603
Dec ’23₹106.95
₹95.67
-10.6%
14.4%₹115.00₹84.00₹231.253
Nov ’23₹88.55
₹93.00
+5.0%
16.8%₹115.00₹80.00₹137.053

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Star Health and Allied Insurance

₹271.5b

Provides health insurance products in India.

543412

₹457.90

7D

-3.5%

1Y

-17.8%

Star Health and Allied Insurance

₹271.5b

Provides health insurance products in India.

STARHEALTH

₹457.95

7D

-3.5%

1Y

-17.8%

General Insurance Corporation of India

₹651.4b

Provides reinsurance services in India and internationally.

540755

₹366.20

7D

3.4%

1Y

38.9%